Human Serum Complement Requirements for Bacterial Killing and Protoplast Lysis of Escherichia coli ML308 225
- 1 March 1981
- journal article
- research article
- Published by Microbiology Society in Microbiology
- Vol. 123 (1) , 179-181
- https://doi.org/10.1099/00221287-123-1-179
Abstract
Normal human serum kills Escherichia coli ML308 225 and lyses protoplasts derived from this organism. Human serum which is depleted of complement component C9 or deficient in component C8 is not bactericidal, but C9-depleted serum will lyse protoplasts whereas C8-deficient serum will not. Bacterial lipopolysaccharide, which can protect bacteria from the serum bactericidal reaction, does not protect protoplasts from lysis by serum.This publication has 6 references indexed in Scilit:
- Analysis of outer membrane components of Escherichia coli ML308 225 and of a serum-resistant mutantInfection and Immunity, 1980
- The Effect of Purified Lipopolysaccharide on the Bactericidal Reaction of Human Serum ComplementMicrobiology, 1980
- Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins.The Journal of Experimental Medicine, 1979
- Interaction of Salmonella typhimurium with phospholipid vesicles. Incorporation of exogenous lipids into intact cells.Journal of Biological Chemistry, 1977
- Protoplast Formation in Escherichia coliJournal of Bacteriology, 1976
- Immune Lytic Transformation: A State of Irreversible Damage Generated as a Result of the Reaction of the Eighth Component in the Guinea Pig Complement SystemThe Journal of Immunology, 1968